- Home
- TXMD vs TRIB Comparison
TXMD vs TRIB Comparison
Compare TXMD & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- TRIB
- Stock Information
- Founded
- TXMD 2008
- TRIB 1992
- Country
- TXMD United States
- TRIB Ireland
- Employees
- TXMD N/A
- TRIB N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TXMD Health Care
- TRIB Health Care
- Exchange
- TXMD Nasdaq
- TRIB Nasdaq
- Market Cap
- TXMD 13.5M
- TRIB 14.0M
- IPO Year
- TXMD N/A
- TRIB N/A
- Fundamental
- Price
- TXMD $1.17
- TRIB $0.79
- Analyst Decision
- TXMD
- TRIB
- Analyst Count
- TXMD 0
- TRIB 0
- Target Price
- TXMD N/A
- TRIB N/A
- AVG Volume (30 Days)
- TXMD 35.3K
- TRIB 2.4M
- Earning Date
- TXMD 08-11-2025
- TRIB 08-13-2025
- Dividend Yield
- TXMD N/A
- TRIB N/A
- EPS Growth
- TXMD N/A
- TRIB N/A
- EPS
- TXMD N/A
- TRIB N/A
- Revenue
- TXMD $1,841,000.00
- TRIB $61,555,000.00
- Revenue This Year
- TXMD $427.09
- TRIB $13.51
- Revenue Next Year
- TXMD N/A
- TRIB $13.14
- P/E Ratio
- TXMD N/A
- TRIB N/A
- Revenue Growth
- TXMD 53.55
- TRIB 8.31
- 52 Week Low
- TXMD $0.70
- TRIB $0.48
- 52 Week High
- TXMD $2.44
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- TXMD 47.76
- TRIB 61.96
- Support Level
- TXMD $1.13
- TRIB $0.72
- Resistance Level
- TXMD $1.24
- TRIB $0.79
- Average True Range (ATR)
- TXMD 0.09
- TRIB 0.09
- MACD
- TXMD 0.01
- TRIB 0.02
- Stochastic Oscillator
- TXMD 73.12
- TRIB 75.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.